StockClub

FNCH

FNCHFinch Therapeutics Group, Inc.$ --
Finch Therapeutics Group, Inc.

Finch Therapeutics Group, Inc.

FNCH

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 06/30/2024FY2024 Q2
Revenue
0M USD
YoY -
Operating Income
-6M USD
YoY +38.2%
Net Income
-5M USD
YoY +30.4%
EPS
-3.01$
YoY +30.5%

Revenue

$0
FY2022 Q3$853,000
$853,000
Q3
FY2022 Q4$861,000
$861,000
Q4
FY2023 Q1$107,000
$107,000
Q1
FY2023 Q2$107,000
$107,000
Q2
FY2023 Q3$107,000
$107,000
Q3
FY2023 Q4$3M
$3M
Q4
FY2024 Q1$0
$0
Q1
FY2024 Q2$0
$0
Q2
Actual
$-107,000 (-100.0%)

Net Income

$-8.7M
FY2022 Q3$-87.4M
$-87.4M
Q3
FY2022 Q4$-113.8M
$-113.8M
Q4
FY2023 Q1$-63.9M
$-63.9M
Q1
FY2023 Q2$-70.9M
$-70.9M
Q2
FY2023 Q3$-73.3M
$-73.3M
Q3
FY2023 Q4$-76.3M
$-76.3M
Q4
FY2024 Q1$-3.9M
$-3.9M
Q1
FY2024 Q2$-8.7M
$-8.7M
Q2
Actual
+$62.2M (+87.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019
Actual:$10.2M
FY2019
$10.2M
FY2020
Actual:$7.7M
FY2020
$7.7M
FY2021MISS
Actual:$18.5M
Est:$20.2M
FY2021MISS
$18.5M
FY2022MISS
Actual:$861,000
Est:$1.3M
FY2022MISS
$861,000
FY2023BEAT
Actual:$107,000
Est:$100,000
FY2023BEAT
$107,000
FY2024IN-LINE
Actual:$0
Est:$0
FY2024IN-LINE
$0

Analyst Estimates